Disclaimer:

Disclaimer: The blog posts and comments on this blog and posts on social networks are not investment recommendation, are provided solely for informational purposes, and do not constitute an offer or solicitation to buy or sell any securities. The opinions expressed on the blog are Petar Posledovich's. Petar Posledovich does not guarantee the accuracy of the information presented on this blog and social networks. The information presented is "as is". The blog is stocks analysis and valuation, Bitcoin, Cryptocurrencies, Artificial Intelligence, AI, deep-learning focused. Independent, unbiased AI insights. Petar Vladimirov Posledovich is not liable for any investment losses incurred by reading and interpreting blog posts on this blog and posts on social networks. Conflicts of interest: I may possess some of the securities, currencies or their derivatives mentioned in the blog post and posts on social networks! The blog is property of Wolfteam Ltd. www.wolfteamedge.com Respectfully yours, Petar Posledovich

Sunday, October 8, 2023

Hologic Valuation


Hologic, Inc the medical technology company is slightly overvalued, according to Wolfteam Ltd.

With 4.86 billion USD revenue, decreasing with 13.66 %, net profit margin of 26.77 %, which is high, Hologic's intrinsic value is 15 billion USD compared to Hologic's market capitalization of 17.11 billion USD, according to Wolfteam Ltd.'s revenue and profitability projections and comparables estimates.

If Hologic goes on decreasing its revenue, the Hologic's intrinsic worth will fall even more.



Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)